The Vanguard Group, Inc. recently announced the acquisition of new stake in Chewy Inc (NYSE:CHWY). The institutional investor has increased its shareholding in the Consumer Cyclical company by 4.24% to 8.36 million shares with purchase of 0.34 million shares. This fresh investment now brings its stake to 6.95% valued currently at $197.5 million. In addition, Voya Investment Management Co. LL raised its holdings by 12576.0 to 5.13 million shares. And Neuberger Berman Investment Advis has lifted its position by 219.06% or 2.55 million shares – to 3.71 million shares.
Currently, there are 431.41M common shares owned by the public and among those 117.35M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 46 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 12 of these insider trades were purchases, accounting for 478,565 shares. Insider sales of the common stock occurred on 34 occasions, with total insider shares sold totaling 29,665,786 shares.
The top 3 mutual fund holders in Chewy Inc are Allianz Global Investors Fund – I, Morgan Stanley Invt. Fds. – US Ad, and Vanguard US Growth Fund. Allianz Global Investors Fund – I owns 4.74 million shares of the company’s stock, all valued at over $111.98 million. Morgan Stanley Invt. Fds. – US Ad sold -0.41 million shares to see its total holdings shrink to 4.1 million shares valued at over $96.96 million and representing 3.41% of the shares outstanding. Vanguard US Growth Fund sold -0.23 million shares to bring its total holdings to over 3.84 million shares at a value of $90.64 million. Vanguard US Growth Fund now owns shares totaling to 3.19% of the shares outstanding.
However, the script later moved the day high at 20.42, up 1.50%. The company’s stock has a 5-day price change of 2.61% and 16.49% over the past three months. CHWY shares are trading -16.89% year to date (YTD), with the 12-month market performance down to -50.78% lower. It has a 12-month low price of $16.53 and touched a high of $52.88 over the same period. CHWY has an average intraday trading volume of 9.73 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.93%, -4.57%, and -27.61% respectively.
Institutional ownership of Chewy Inc (NYSE: CHWY) shares accounts for 24.11% of the company’s 431.41M shares outstanding. Mutual fund holders own 38.78%, while other institutional holders and individual stakeholders account for 47.70% and 17.18% respectively.
It has a market capitalization of $8.47B and a beta (3y monthly) value of 0.94. The stock’s trailing 12-month PE ratio is 741.13, while the earnings-per-share (ttm) stands at $0.03. The company has a PEG of 28.89 and a Quick Ratio of 0.60 with the debt-to-equity ratio at 1.41. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.12% over the week and 4.79% over the month.
Analysts forecast that Chewy Inc (CHWY) will achieve an EPS of -$0.04 for the current quarter, $0.06 for the next quarter and $0.13 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.1 while analysts give the company a high EPS estimate of $0.04. Comparatively, EPS for the current quarter was $0.01 a year ago. Earnings per share for the fiscal year are expected to decrease by -100.95%, and 12819.23% over the next financial year.
Looking at the support for the CHWY, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on January 11, 2024, with the firm’s price target at $19-$30.
